BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
14 mai 2024 16h02 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
27 mars 2024 16h00 HE
|
BioCardia, Inc.
BioCardia®, Inc. today reported financial results for the year ended December 31, 2023